Third-Party Review of 510(k)
Program in which FDA-accredited third parties conduct the initial 510(k) review for eligible device types.
Definition
Eligible Class I and Class II device 510(k)s can be reviewed by an FDA-accredited Third Party Review Organization, which submits a recommendation to FDA. Final clearance still rests with FDA.What this means in practice
Used to compress timelines for well-established product types; not all product codes are eligible.Examples
- A manufacturer of a new, conventional blood glucose meter opts for third-party review to potentially accelerate its 510(k) clearance process.
- A company developing a surgical tool with a well-established predicate device chooses a Third-Party Review Organization to handle the initial technical review of their 510(k) submission.
- A medical device startup with limited internal regulatory resources uses a third-party reviewer to leverage their expertise and streamline the 510(k) submission for a Class II diagnostic imaging accessory.
- •A common pitfall is submitting an eligible 510(k) to a Third-Party Review Organization without ensuring the device falls within the specific product codes and limitations accepted by that particular organization.
- •Another mistake is assuming that third-party review guarantees faster clearance, as the FDA still performs an administrative review and can request additional information, impacting the overall timeline.
- •Companies sometimes fail to perform due diligence on the accreditation and experience of a Third-Party Review Organization, potentially leading to incomplete reviews or delays.
- •Misunderstanding that the third-party reviewer acts on behalf of the manufacturer, not as a representative of the FDA, can lead to compliance issues.
- •Failing to prepare the 510(k) submission to the same standard as a direct FDA submission is a pitfall, as third-party reviewers adhere to FDA requirements and expectations.
Frequently asked questions
Related terms
Grouped by themeEditor's picks
· Hand-selected related conceptsMore in Regulatory
· Same categoryTwo alternative disclosure mechanisms in a 510(k) submission, a Summary is public on FDA's website; a Statement promises to share Safety & Effectiveness info on request.
Formal mechanism to ask FDA whether a product is a device and, if so, its likely classification.
FDA voluntary program in which accredited testing labs perform standards-based testing accepted with reduced FDA scrutiny.
FDA's 2024 final rule creating a pathway for nonprescription drug products that rely on additional conditions (e.g., self-selection tools, drug-device combinations) to ensure safe use without a healthcare provider.
Primary references
3 sources- 1
FDA - Medical DevicesVerifiedFDAfda.gov
- 2
European Commission - Medical DevicesVerifiedEuropean Commissionhealth.ec.europa.eu
- 3
IMDRF DocumentsVerifiedIMDRFimdrf.org
Inline markers like [1] jump to the matching reference above.